Document is current
Any future updates will be listed below
-
Authors
Dogra, Samrita
Adhikari, Laura
Benbrook, Doris M.
Bohn, Jacqueline A.
Burgett, Anthony
Chandra, Vishal
Dockery, Lauren
Singh, Amit
McNally, Lacey
Rai, Rajani
Isingizwe, Zitha Redempta
Richardson, Debra L.
Yang, Zhibo
Hannafon, Bethany N.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30CA225520)
Congressionally Directed Medical Research Programs (HT94252310175, HT94252310223)
Ovarian Cancer Research Alliance (CRDG-2024-3-1550)
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 11 August 2025
First Online: 14 October 2025
Declarations
:
: Not applicable.
: All authors have read and approve of the manuscript.
: DLR receives consulting fees from Daiichi Sankyo, Genmab, GSK, Incyclix, Repare, and Immunogen, and speaking fees from Zentalis. The remaining authors declare that they have no affiliation with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.
